Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023)

Bicycle Therapeutics (BCYC) has disclosed Construction in Progress for 2 consecutive years, with $400000.0 as the latest value for Q2 2023.

  • For Q2 2023, Construction in Progress changed N/A year-over-year to $400000.0; the TTM value through Jun 2023 reached $400000.0, changed N/A, while the annual FY2022 figure was $2.3 million, N/A changed from the prior year.
  • Construction in Progress hit $400000.0 in Q2 2023 for Bicycle Therapeutics, down from $2.3 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $2.3 million in Q4 2022 and bottomed at $400000.0 in Q2 2023.